Vaccines against different SARS-CoV-2 variants have been approved, but continued surveillance is needed to determine when the antigen composition of vaccines should be updated, together with clinical studies to assess vaccine efficacy.
- Rebecca Grant
- Jilian A. Sacks
- Kanta Subbarao